Indication
Maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist (for effects on symptoms control and prevention of exacerbations see section 5.1).
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Trydonis 87 Microgramos/5 Microgramos/9 Microgramos Solucion Para Inhalacion en Envase A PresionSpain · 0,1 mg + 0.006 mg + 0.0125 mgMarketed
- Trydonis 88 Microgramos/5 Microgramos/9 Microgramos Polvo Para InhalacionSpain · 100 µg + 6 µg + 12,5 µgMarketed
- Trydonis 87 microgram/5 microgram/9 microgram aërosol, oplossingNetherlandsAuthorised
- Trydonis 88 microgram/5 microgram/9 microgram, inhalatiepoederNetherlandsAuthorised